Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR
NCT01076153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 760
Last updated 2011-07-12
Summary
The investigators hypothesize that Klacid modified release (MR) shortens symptom recovery time in Thai patients with upper or lower respiratory tract infections.
Conditions
- Respiratory Tract Infection
Interventions
- DRUG
-
Clarithromycin (Klacid® MR)
Klacid MR 500mg (clarithromycin)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Savary Om, M.D. · Abbott
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2010-04-30
- Completion
- 2010-04-30
Countries
- Thailand
Study Locations
More Related Trials
-
Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Patients With Acute Exacerbation of Chronic Bronchitis
NCT01354938 ·Status: COMPLETED
-
Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)
NCT01075204 ·Status: COMPLETED
-
Outpatient Registry Trial of Respiratory Tract Infections in Adults
NCT00245453 ·Status: WITHDRAWN ·Phase: PHASE4
-
Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Oral Flora
NCT00354952 ·Status: COMPLETED ·Phase: NA
-
KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections
NCT00132951 ·Status: TERMINATED ·Phase: PHASE4
-
Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections
NCT04016051 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis
NCT00649831 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis
NCT00645086 ·Status: COMPLETED ·Phase: PHASE3
-
Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections
NCT00827502 ·Status: COMPLETED
-
CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
NCT03236987 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Azithromycin Prophylaxis in Preventing Recurrent Acute Sinusitis in Children
NCT00944515 ·Status: COMPLETED ·Phase: NA
-
The Effect of Azithromycin in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Productive Cough
NCT01071161 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep Throat
NCT00643539 ·Status: COMPLETED ·Phase: PHASE4
-
Telithromycin in Respiratory Tract Infections
NCT00261105 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label Trial of Azithromycin in Chronic Productive Cough
NCT02196493 ·Status: UNKNOWN ·Phase: PHASE3
-
Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease
NCT00598897 ·Status: COMPLETED ·Phase: PHASE4
-
An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia
NCT00648726 ·Status: COMPLETED ·Phase: PHASE3
-
PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis
NCT00132938 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI)
NCT04322669 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days
NCT00237445 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate
NCT02340000 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients
NCT00643227 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination Therapy vs. Oseltamivir Alone for Hospitalised Paediatric Influenza Patients
NCT04315194 ·Status: COMPLETED
-
Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers
NCT01199536 ·Status: COMPLETED
-
Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia
NCT00035347 ·Status: COMPLETED ·Phase: PHASE4